Back
Merck & 10K Form
Sell
25
MRK
Merck &
Last Price:
101.65
Seasonality Move:
4.09%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2010-03-30 | 10K | MRK/Merck & Annual |
| 2009-11-02 | 10Q | MRK/Merck & Quarterly |
| 2009-08-03 | 10Q | MRK/Merck & Quarterly |
| 2009-05-04 | 10Q | MRK/Merck & Quarterly |
| 2009-02-27 | 10K | MRK/Merck & Annual |
| 2008-11-03 | 10Q | MRK/Merck & Quarterly |
Receive MRK News And Ratings
See the #1 stock for the next 7 days that we like better than MRK
MRK Financial Statistics
Sales & Book Value
| Annual Sales: | $60.12B |
|---|---|
| Cash Flow: | $4.85B |
| Price / Cash Flow: | 0 |
| Annual Sales: | $17.19 |
| Price / Book: | 5.92 |
Profitability
| EPS (TTM): | 4.77000 |
|---|---|
| Net Income (TTM): | $12.15B |
| Gross Margin: | $43.99B |
| Return on Equity: | 34.04% |
| Return on Assets: | 11.25% |
Merck & Earnings Forecast
Key Merck & Financial Ratios
- The Gross Profit Margin over the past 40 years for MRK is 73.17%.
- The Selling, General & Administrative Expenses for MRK have been equal to 17.47% of Gross Profit Margin.
- The Research & Development expenses have been 50.79% of Revenue.
- The Interest Expense is 313.97% of Operating Income.
- The Net Earning history of MRK is 0.61% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 24 years.
Merck & Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | MRK |
| CUSIP: | 58933Y |
| Website: | merck.com |
Debt
| Debt-to-Equity Ratio: | 0.87 |
|---|---|
| Current Ratio: | 1.47 |
| Quick Ratio: | 0.88 |
Price-to-Earnings
| Trailing P/E Ratio: | 727.64 |
|---|---|
| Forward P/E Ratio: | 10.68 |